ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis.

M. Lim,1 D. Sawinski,1 J. Cohen,1,2 B. Weiss,3,4 J. Hogan,1,3 L. Dember.1,3

1Renal, Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA
2Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
3Penn Amyloidosis Program, Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
4Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA

Meeting: 2017 American Transplant Congress

Abstract number: 346

Keywords: Kidney transplantation, Malignancy, Mortality, Outcome

Session Information

Date: Monday, May 1, 2017

Session Name: Concurrent Session: Kidney Clinical Complications 2

Session Time: 4:30pm-6:00pm

 Presentation Time: 4:42pm-4:54pm

Location: E354b

Related Abstracts
  • Using Gastrointestinal Biopsy to Predict Outcome in Patients Evaluated for Cardiac Transplantation for Amyloidosis: A Report from the International Consortium on Cardiac Amyloidosis Transplantation (iCCAT).
  • Multi-Center, International Registry of Cardiac Transplantation for Light Chain (AL) and Transthyreitin (TTR) Amyloidosis, A

Background: Data on patient and graft outcomes of kidney transplant recipients with end stage renal disease (ESRD) from systemic amyloidosis is scarce. Methods: We performed a retrospective cohort study using data from the United Network of Organ Sharing in patients transplanted from 1987 to 2015. We used multivariable Cox regression with and without propensity score matching to assess patient and graft outcomes of 576 patients with ESRD due to amyloidosis compared to 310,053 non-amyloidosis patients. Because diabetes and age were identified as significant effect modifiers, we also performed sensitivity analyses comparing patient and graft survival of amyloid patients to only those with ESRD listed as due to diabetes (DN), and to the elderly (age > 65 years at the time of transplant). Results: Amyloidosis patients were older (median age 57 vs. 50 yrs; p<0.001), more often Caucasian (81% vs 56%, p<0.001) and less likely to have received a deceased donor transplant (52% vs. 64%, p<0.001). In multivariable Cox regression they had higher rates of death (HR 1.85, 95%CI 1.60-2.13) and all cause graft loss (HR 1.62, 95% CI 1.38-1.89). In a 1:1 propensity score matched Cox analysis, amyloid patients had elevated rates of death (HR 1.37, 95% CI: 1.08-1.74) and graft loss (HR 1.66, 95% CI 1.30-2.12) compared to the non-amyloid patients, but had a similar risk of death (HR 0.83, 95% CI 0.65-1.06) and graft failure (HR 0.96, 95% CI 0.72-1.27) when compared to DN or elderly recipients (death, HR 0.83, 95% CI 0.57-1.20 and graft loss HR 0.85, 95% CI 0.56-1.28, respectively). Conclusion: Patient and graft survival are worse for patients with amyloidosis-associated ESRD than for those with other causes of ESRD, but are comparable to the elderly and to patients with ESRD from diabetic nephropathy.

CITATION INFORMATION: Lim M, Sawinski D, Cohen J, Weiss B, Hogan J, Dember L. Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Lim M, Sawinski D, Cohen J, Weiss B, Hogan J, Dember L. Patient and Kidney Allograft Survival in Recipients with End Stage Renal Disease from Amyloidosis. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/patient-and-kidney-allograft-survival-in-recipients-with-end-stage-renal-disease-from-amyloidosis/. Accessed January 25, 2021.

« Back to 2017 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Left-Sided Donor Nephrectomy Predisposes Living Kidney Donors to Latent Adrenal Insufficiency with Symptoms of Fatigue and Inferior Quality of Life.
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.